Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

Yakult misses Q4 2026 earnings forecast significantly – shares fall

Yakult reported Q4 2026 earnings per share of ¥9.18 versus an expected ¥17.01, missing the forecast by 46.03%. Revenue was ¥114.65bn, slightly below the expected ¥115.01bn, and the stock fell 3.63% after the release. Declining domestic sales were partly offset by a recovery in overseas markets; management plans product innovation and efficiency measures to counter margin‑pressuring cost headwinds and a stagnant home market. » More on de.investing.com
YAKULT HONSHA with slightly lower revenue and increased annual EPS

YAKULT HONSHA reported quarterly EPS of 0.03 USD for the quarter ended March 31, 2026, compared with 0.020 USD a year earlier, and revenue of 730.7 million USD (prior year 744.2 million, -1.81%). For the fiscal year, EPS was 0.500 USD versus 0.490 USD in the prior year. Annual revenue fell to 3.23 billion USD from 3.28 billion USD in the prior year (-1.52%). » More on finanzen.net
Yakult beats EPS forecast, misses revenue expectations and shares fall

Yakult reported Q2 2025 EPS of ¥44.05 versus a forecast of ¥41.6, while revenue of ¥124.59bn missed the expected ¥127.91bn. The stock fell 5.04% after the results, closing at ¥2,582. Causes cited include a stronger yen, lower domestic sales volumes and higher costs; however, overseas business grew, notably in China and Vietnam. The company slightly trimmed its full-year forecast and is counting on marketing, new products and overseas expansion to drive a recovery in H2. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2026, YAKULT HONSHA has already paid €0.20 in dividends. The last payout was in June.

Financials

In the last quarter, YAKULT HONSHA had revenue of €648.97m and net profit of €73.22m

(EUR)	June 2026	YoY
Revenue	648.97m	5.65%
Gross profit	386.15m	4.66%
Net profit	73.22m	7.02%
EBITDA	93.55m	39.18%

Fundamentals

Metric	Value
Market capitalization	€4.62bn
Number of shares	287.72m
52-week high/low	€17.56 - €13.01
Dividend yield	2.38%
Dividends TTM	€0.38
Beta	-0.12
P/E ratio	17.84
PEG ratio	1.67
P/B ratio	1.36
P/S ratio	1.66

Company profile

Yakult Honsha Co.,Ltd. manufactures and sells food and beverage products, cosmetics, pharmaceuticals, and others. It operates through Food and Beverages (Japan), Food and Beverages (The Americas), Food and Beverages (Asia and Oceania), Food and Beverages (Europe), Pharmaceuticals, and Others segments. The company offers fermented milk drinks, juices, noodles, etc. through its home delivery and retail store channels. It also provides pharmaceutical products, such as Elplat, an antineoplastic drug, as well as generic anti-cancer agents, including Gemcitabine Yakult, Capecitabine, and Gefitinib Yakult tablets. In addition, the company offers cosmetics; and operates the Tokyo Yakult Swallows, a professional baseball team. Yakult Honsha Co.,Ltd. was founded in 1935 and is headquartered in Tokyo, Japan.